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Cells communicate with one another to create microenvironments and share resources. One avenue by
which cells communicate is through the action of exosomes. Exosomes are extracellular vesicles that are
released by one cell and taken up by neighbouring cells. But how exosomes instigate communication
between cells has remained largely unknown. We present evidence here that particular long non-coding
RNA molecules are preferentially packaged into exosomes. We also ﬁnd that a speciﬁc class of these
exosome associated non-coding RNAs functionally modulate cell viability by direct interactions with L-
lactate dehydrogenase B (LDHB), high-mobility group protein 17 (HMG-17), and CSF2RB, proteins
involved in metabolism, nucleosomal architecture and cell signalling respectively. Knowledge of this
endogenous cell to cell pathway, those proteins interacting with exosome associated non-coding tran-
scripts and their interacting domains, could lead to a better understanding of not only cell to cell in-
teractions but also the development of exosome targeted approaches in patient speciﬁc cell-based
therapies.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Exosomes are 40e100 nm extracellular vesicles secreted by
mammalian cells, the result of multivesicular endosome fusion to
the cells plasma membrane. These extracellular particles are
involved in intercellular communication by acting as transport
vehicles for proteins and RNA, both mRNA and non-coding RNAs
[40]. Small non-coding RNAs, such as miRNAs, as well as long non-
coding RNAs (lncRNAs) have also been observed packaged into
exosomes [17] and found to act as messengers in cell-to-cell
communication [39]. Non-coding RNAs exhibit a plethora of func-
tions, ranging from chromatin and enhancer modiﬁers to scaf-
folding and transcript sponge functions [22]. Some lncRNAs such as
MALAT1 and NEAT1 have also been found to function in cancer cell
signalling [2,3,5e8,18,20,28], with MALAT1 being previously
observed to be packaged into exosomes [5].esearch Institute, Center for
nications Co., Ltd.
ing by Elsevier B.V. on behalf of Ke
d/4.0/).
n, et al., Extracellular vesicle
.doi.org/10.1016/j.ncrna.2016.One possible mode of action for these particular lncRNAs might
be to act distally in the creation of a pre-metastatic niche for
metastatic cells [1,10]. We set out to explore this notion and ﬁnd a
set of exosome-associated lncRNAs that functionally modulate cell
viability by interactions with several proteins involved in cellular
metabolism and signalling. Previous studies have identiﬁed that
RNA content can be dependent on the cell type from which it
originated from. This has led to an increase in the investigation of
exosomal RNAs as possible biomarkers for a variety of cancers
[26,27,33]. It has also been observed that Viruses are capable of
affecting RNA content within exosomes, which can repress the
target genes of the virus [4,29]. In light of these discoveries we set
out to determine whether a cervical cancer affected by the HPV
virus (in this case Hela) affect the RNA content in the exosome
when compared to a cervical cell line without HPV (C33A).Ai Communications Co., Ltd. This is an open access article under the CC BY-NC-ND
associated long non-coding RNAs functionally enhance cell viability,
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2.1. Cell culture
Hela and C33A cells were cultured in Dulbecco's Modiﬁed Ea-
gle's Medium supplemented with 10% fetal bovine serum, 1%
penicillin-streptomycin solution and 2 mM L-glutamine. The cells
were grown in T-175 ﬂasks at 37 C and 5% CO2. Cultures were
passaged when they were ~90% conﬂuent. The media was removed
from the cells and they were washed with 8 mL of 1X PBS. Trypan
blue exclusion was used to assess cell viability and estimate cell
numbers.2.2. Calcium phosphate transfection of Hela cells
Hela cellswere transfectedwith 5-Bromouridine 50-Triphosphate
(BrUTP) using the calcium phosphate transfection method [15].
When cells take up the BrUTP, it is utilised in transcription and
incorporated into RNA transcripts causing them to be labelled. The
BrUTP-labelled transcripts are packaged into exosomes, which are
isolated from the cell culture media, described below. One day prior
to transfection, 100 mm cell culture plates were seeded with
approximately 2 million Hela cells and the volume of each dish was
madeup to 10mLwith freshmedia. For eachplate, a transfectionmix
wasmade byadding500 mL of 1XHBS and0.5mL of 10mMBrUTP to a
sterile microcentrifuge tube and vortexing to mix. To each trans-
fection mix 30 mL of 2.5 M calcium chloride was added. The tubes
were mixed by vortexing and left to sit at room temperature for
20 min. The calcium phosphate transfection mix was added to each
plate drop-wise andmixedby rocking. Theﬁnal BrUTP concentration
in each platewas 0.5 mM. Exosomes from the cell culturemediawere
collected over a 3 day period post-transfection.2.3. Exosome isolation
Exosomes were isolated from conditioned media as they are
secreted by cells into the culture media. During cell passaging, the
conditioned media was collected and centrifuged at 700 g for
5 min to remove any live cells. The conditioned media was stored
at 20 C. To isolate exosomes from the conditioned media, ultra-
centrifugation on a 30% sucrose density cushion was used. The
conditioned media was centrifuged at 10,000 g for 30 min with a
Hitachi P28S rotor to remove any dead cells or cellular debris. The
supernatants were then transferred to clean 40 PA tubes and
centrifuged at 100,000 g for 90 min in the P28S rotor to pellet the
exosomes and contaminating proteins. The supernatant was dis-
carded and the pellet was resuspended with 1 mL of 1X PBS. The
resuspended exosomes were pooled together and the total volume
was made up to 9 mL with 1X PBS. In a 13 PA tube, 1 mL of the 30%
sucrose density cushion (30 g sucrose, 2.4 g Tris base, 100 mL
deuterium oxide, pH 7.4) was added and the resuspended exosome
solution was placed above the sucrose cushion. Great care was
taken not to disturb the interface between the two solutions. Using
a Hitachi P40S rotor, the sucrose cushion and exosome solutionwas
centrifuged at 100,000 g for 90 min. During this ultracentrifuga-
tion step contaminating proteins are pelleted while the exosomes
ﬂoat in the sucrose cushion. The sucrose cushionwas transferred to
a clean 13 PA; 9 mL of 1X PBS was added and the exosomes were
washed by centrifuging at 100,000 g for 90 min. The supernatant
was removed and ﬁnal exosome pellet was resuspended in 100 mL
of 1X PBS. All centrifugation steps were performed at 4 C using a
Hitachi HiMac CP100WX ultracentrifuge. A Bradford protein assay
(Bio-Rad) was performed to estimate the exosome concentration.Please cite this article in press as: C. Hewson, et al., Extracellular vesicle
Non-coding RNA Research (2016), http://dx.doi.org/10.1016/j.ncrna.2016.2.4. Western blot of exosomal markers
Western blots of exosomal markers CD9, CD63 and ﬂotillin-1
were performed to conﬁrm the isolation of exosomes. The cellular
protein calnexinwas also analysed as a control, as it is not present in
exosomes. The anti-CD9 and anti-CD63 antibodies required non-
reducing conditions while reducing conditions were required for
the anti-ﬂotillin-1 and anti-calnexin antibodies required. Hela
exosomes (10 mg) and cells (105) were mixed with either non-
reducing sample buffer (4X Laemmli sample buffer) or reducing
sample buffer (4X Laemmli sample buffer with 10% 2-
mercaptoethanol) depending on the condition required by the
speciﬁc antibody. The samples in the reducing bufferwere heated at
95 C for 10 min. The samples and Precision Plus Protein Kaleido-
scope Standard were loaded onto a 4e20% gradient Mini-PROTEAN
TGX precast gel. Electrophoresis was performed at 150 V for 45 min
in 1X Tris/Glycine/SDS buffer. The proteins in the gel were trans-
ferred onto to a PVDF membrane using a Bio-Rad Mini-Trans Blot
Electrophoretic Transfer Cell at 90 V for 1 h in 1X Tris/glycine buffer
with 20% methanol. The PVDF membranes were blocked overnight
at 4 C in 15 mL of 1X PBS/5% skim milk/0.1% Tween-20 blocking
solution. The anti-CD9 (ab2215), anti-CD63 (ab59479) and anti-
calnexin (ab21290) primary antibodies were diluted 1:1000 in
blocking solution and the anti-ﬂotillin-1 antibody (ab41927) was
diluted 1:500. The membranes were incubated with 3 mL of a
speciﬁc primary antibody solution for 4 h at room temperature on a
shaking platform. They were thenwashed three times for 10 min in
50 mL of 1X PBS/0.1% Tween-20 at room temperature with shaking.
The anti-mouse IgG horseradish peroxidase conjugate secondary
antibody (Bio-Rad) was diluted 1:3000 times in blocking solution.
The membranes were incubated in 3 mL of secondary antibody
solution for 1 h at room temperature with shaking before being
washed again three times. Bound secondary antibodies were col-
ourimetrically detected using an Opti-4CN Substrate Kit.2.5. Electron microscopy of exosomes
Electron microscopy of exosomes was performed by Rebekka
Williams of the Children's Cancer Institute Australia (as a fee for
service) to conﬁrm that exosomes were isolated from conditioned
cell culture media. A 10 mL suspension of Hela exosomes was ﬁxed
with 2% glutaraldehyde for 30 min. The ﬁxed exosomes (5 mL) were
dropped onto 300 mesh carbon coated formvar-copper TEM grids
and left to settle for 15min. Excess samplewas removed bywicking
with ﬁlter paper and the grids were washed with water droplets.
The exosomes were negatively stained by placing the grid on a
droplet of 2% uranyl acetate for 2min and any excess waswicked off
using ﬁlter paper. A Joel JEM-1400 transmission electron micro-
scopewas used to image the grids. Negative control grids containing
no exosomes (only glutaraldehyde and PBS) were also prepared.2.6. Sequencing of exosomal RNA
The Ramaciotti Centre for Gene Function Analysis performed
library preparation and sequencing of Hela and C33A exosomal RNA
on an Illumina HiSeq 2000 as a fee for service. The 100 bp paired
end reads generated by RNA sequencing were analysed by ﬁrst
quality control performed using FastQC v0.10.1 available from
http://www.bioinformatics.babraham.ac.uk/projects/fastqc. Reads
were quality ﬁltered, trimmed and adapter sequences were
removed using Trimmomatic v0.3.0 [21]. Reads were then aligned
to the hg19 Homo sapiens genome with tophat2 (v2.0.8b) using the
default settings except for the following (–b2-sensitive) [14].
Transcripts were assembled using Cufﬂinks v2.1.1 [38]. Allassociated long non-coding RNAs functionally enhance cell viability,
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determined using cuffdiff.
2.7. Fluorescence-activated cell sorting (FACS)
FACS was used to demonstrate the transfer of RNA from exo-
somes into recipient cells. This was achieved by exposing C33A cells
to Hela exosomes (20 ml) containing either normal RNA or BrUTP-
labelled RNA for 24 or 48 h. The exosome exposed cells were
collected, permeabilised and stained with an anti-BrdU primary
antibody (B8434) and an IgG-FITC secondary antibody (F0257)
(SigmaeAldrich). The C33A exosome exposed cells were analysed
with a BD Biosciences FACSCanto II ﬂow cytometer at the Biological
Resources Imaging Laboratory at UNSW as a fee for service.
2.8. Chromatin immunoprecipitation of biotin linked RNAs
Chromatin immunoprecipitation (ChIP) was performed on T7
expressed biotin dUTP containing lncNRAs (Table S1). The biotin
RNAs were generated as described in [13,32]. The Biotin containing
RNAs were transfected into HEK293 cells and CHIP carried out 48 h
later (as described in [13]). The enrichment of the various RNAs at
predicted target loci (Fig. S2) was determined by qPCR with various
primers (Table S2).
2.9. Immunoprecipitation and mass spectrometry of RNA associated
proteins
Proteins associated with exosomal RNAs were determined by
transfection of biotin labelled RNAs (Table S1) into 293HEK cells
and immunoprecipitation carried out 48 hrs later from either the
cells or exosomes collected from the transfected cells (as described
in [9,32]). The resultant elutes were then analysed by mass spec-
trometry using the fee for service Bioanalytical Mass Spectrometry
Facility at UNSW.
3. Results
To explore the notion that particular lncRNAs are preferentially
packaged into exosomes we collected extracellular particles con-
taining exosomes from cultures grown in pre-cleared conditions
(Fig. 1AeB). Western blot analysis for exosomal markers CD9 and
Flotillin-1 contrasted with the cellular protein Calnexin [36]
conﬁrmed that the predominant isolate from the extracellular
particles utilized here contained known exosomal associated pro-
teins (Fig. 1C). CD9 is a tetraspanin found in cells but also recog-
nized as an exosomal marker as they are found highly enriched on
the surface of exosomes and Flotillin-1 is a lipid raft associated
protein found in exosomes while Calnexin is an endoplasmic re-
ticulum protein predominately localized in the cell [37]. Collec-
tively, these data suggest that our protocol, based on [31,37] results
in the isolation of exosome associated proteins.
Next, we sought to determine the predominant species of
lncRNAs associated with these exosomes. Hela and C33A exosomes
were isolated and their RNA content sequenced using Illumina
RNA-sequencing. A strong correlation in the RNA content of Hela
and C33A exosomes was observed as determined and those RNA
transcripts greater than 4 fragments per kilobase of exon per
million fragments mapped (FPKM) plotted against each other
(Fig. 1D). The observed R2 value of 0.9584 suggested that the RNA
content of Hela and C33A exosomes is approximately 96% similar
(Fig. 1D). Notably, some of the previously observed cancer-exosome
associated lncRNAs BCYRN1 [12], MALAT1 [8], GAS5 [16,23,24,34]
and NEAT1 [2,7,20,28,35,41]. were not observed present above
cellular RNAs in the Hela and C33A exosomes assessed here (Fig. 1EPlease cite this article in press as: C. Hewson, et al., Extracellular vesicle
Non-coding RNA Research (2016), http://dx.doi.org/10.1016/j.ncrna.2016.and Table S3). Interestingly, the top 4 most abundant transcript
candidates observed associated with both Hela and C33A exosomes
were un-annotated transcripts emanating from genomic deserts
that contained DNase hypersensitive regions of high histone acet-
ylation as well as RNAPII and CTCF binding sites. Mapping to Hu-
man Feb. 2009 (GRCh37/hg19) assembly suggested that these
transcripts are ribosomal RNAs (Fig. S1AeD). These transcripts
were designated Exo1-4 (Figs. 1E, S1AeD and Tables S1 and S3) and
were contrasted with the enzymatic RNA, RMRP, a mitochondrial
RNA-processing endoribonuclease that is imported into the mito-
chondria to cleave mitochondrial RNA [11], which was also
observed to be lowly associated with the Hela and C33A exosomes
(Fig. 1E, Tables S1 and S2).
Previous studies have demonstrated that lncRNAs can be
transmitted from one cell to another by the action of the exosome
[40]. To determine to what extent the exosome associated tran-
scripts are transmitted between Hela and C33A cells, a BrUTP
cellular RNA labelling assay was performed. In this assay 5-
Bromouridine 50-Triphosphate UTPs (BrUTP) are transfected into
Hela cells and the resultant cellular exosomes collected 24e48 hrs
post-transfection. The exposure of C33A cells to these BrUTP
labelled RNA containing exosomes demonstrated that Hela exo-
somes can transfect C33A cells and disseminate BrUTP transcripts
to ~34% of the treated cells over a 48hr time course (Fig. 2AeC). To
determine to what extent these Hela derived exosomes can affect
HEK293 cell function, HEK293 cells were exposed to Hela cell
derived exosomes. Notably, Hela exosome treatment of HEK293
cells results in signiﬁcant changes in cell viability, suggesting that
these exosomes functionally modulate the recipient target cells
(Fig. 2D). This observed effect on cell viability was dosage depen-
dent, suggesting that the lncRNAs exhibit a bona ﬁde and quanti-
tative effect on the recipient cells (Fig. S2). To determine to what
extent the candidate non-coding RNAs, Exo1-4 and RMRP are
functionally involved in modulating recipient cells, cultures were
transfected and the effects on cell viability determined. All of the
top candidate exosome associated lncRNAs, Exo1-4 and RMRP
functionally enhanced cell viability relative to controls (Fig. 2E).
Collectively these observations suggest that exosomes contain a
subset of lncRNAs that modulate recipient cell function resulting in
enhanced recipient cell viability.
The list of functions of non-coding RNAs continues to expand
[22]. To determine how the exosome-associated lncRNAs Exo1-4
and RMRP might function in the cell, biotin-labelled lncRNAs
were generated, transfected into cells and the resultant complexes
eluted and bound protein partners determined by mass-
spectrophotometry analysis (MS)(Fig. 3A). Interestingly, relative
to the biotin-GFP control transcripts, Exo1-4 and RMRP precipitated
with L-lactate dehydrogenase B (LDHB), high-mobility group pro-
tein 17 (HMG-17), and CSF2RB; proteins involved in metabolism,
nucleosomal architecture and cell signalling respectively (Fig. 3A).
Previous studies have found some lncRNAs can associate with ho-
mologous containing loci in the genome. To determine to what
extent the exosome-associated lncRNAs Exo1-4 and RMRPmight be
targeting the genome a chromatin immunoprecipiation analysis
was carried out with the biotin-labelled lncRNAs. Only RMRP
exhibited any binding to homologous containing genomic loci
relative to the controls (Fig. 3B). Notably, the RMRP binding locus is
on the shoulder of histone acetylation for CCDC107, a gene
expressing a coiled-coil containing membrane protein (Fig. 3C)
which also contains Rho guanine nucleotide exchange factor 39
(ARHGEF39), a gene known to be involved in cell migration, in
overlapping and antisense orientation (Fig. S3). Collectively, these
data suggest that the exosome-associated lncRNAs interact with
particular cellular proteins to affect cell viability and themajority ofassociated long non-coding RNAs functionally enhance cell viability,
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Fig. 1. Analysis of Hela and C33A associated exosomes e (A-B) Detection of exosomes by electron microscope. (A) a negative control grid with no exosomes and (B) a grid containing
Hela exosomes. The Hela exosomes are approximately 40 nme100 nm in size. The three arrows mark exosomes that display the commonly observed cup-shaped morphology. (C)
Western blot of exosomal markers. Western blots for the exosomal markers CD9, Flotillin-1 and Calnexin was performed on Hela exosomal and cellular proteins to conﬁrm that
exosomes were isolated from conditioned cell culture media using ultracentrifugation and a 30% sucrose density cushion. (D) Correlation in the RNA content of Hela and C33A
exosomes. Hela and C33A exosomal RNA transcripts greater than 4 FPKM were plotted against each other and a R2 value of 0.9584 was calculated. (E) Candidate transcripts found in
exosomes from both C33A and Hela cells along with the enrichment of MALAT1, BCYRN1, GAS5 and NEAT1, previously reported in cancer exosomes and the enzymatic RNA RMRP.
The top candidate RNAs Exo1-4 and RMRP and were investigated.
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Fig. 2. Exosomal transfer enhances recipient cell viability e (A-C) Exosomal-mediated RNA transfer into recipient cells was determined. C33A cells exposed to Hela exosomes
containing normal RNA or BrUTP-labelled RNAwere analysed by FACS to determine if RNA can transfer into cells from exosomes. RNA transfer was determined by FITC ﬂuorescence
in cells exposed to exosomes for (A) 24 h or (B) 48 h and (C) the percentage transfer of BrUTP-labelled exsomal RNA determined. (D) Exosomal cell viability of HEK293 cells treated
in triplicate with Hela exosomes or a PBS control. Cell viability was the analysed at 48 and 72 h using the Millipore Muse cell analyser. The effects of the top candidate exosome
associated RNAs expression on cell viability (E) HEK293 cells were transfected in triplicate to overexpress candidate lncRNAs (Exo1-4, and RMRP) along with a GFP control. Lip-
ofectamine only and untransfected cells served as the controls. Cell viability was measured using the Millipore Muse cell analyser at 48 and 72 h post-transfection. For (D-E) Error
bars represent standard error of the mean, *represents P < 0.05 relative to GFP Control 1.
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Fig. 3. Mechanism of exosome associated RNA regulation of cell viability and associated proteins e (A) Biotin containing transcripts Exo1-4, and RMRP were transfected into HEK293
cells and elutes from the ChIP sent for mass spec analysis at the UNSW BMFS facility in triplicate. Proteins present in at least two of the samples and not in the GFP controls were
ﬂagged as candidates of interest. (B) Relative enrichment of the candidate exosome associated RNAs at homology containing loci. Biotin tagged transcripts (Exo1, Exo2 and RMRP
were transfected into HEK293 cells in triplicate and 48 h later immunoprecipitated with steptavidin beads. Enrichment of each biotin transcript is shown at homology containing
loci relative to the GFP control. Error bars represent standard error of the mean,*represents p < 0.05. (C) A UCSC snapshot of the RMRP target locus found enriched by CHIP (in B
above) is shown with the relative CHIP primer binding sites and associated epigenetic state of the locus.
C. Hewson et al. / Non-coding RNA Research xxx (2016) 1e96these interactions, with the exception of RMRP, do not appear to be
chromatin based.
The observations that the exosome associated lncRNAs bound to
particular proteins (Fig. 3B), suggested that either the candidate
lncRNAs bind particular proteins and are packaged into exosomes
or functionally interact with the candidate proteins upon being
introduced into the cells via exosome uptake in recipient cells. To
determine to what extent the exosome associated lncRNAs are
interacting with the candidate proteins in either exosomes or
recipient cells an immunoprecipitation of the candidate proteins
LDH, HGM, CSF and GAPDH (Fig. 3A and B) was carried out in both
cells and exosomes and qRTPCR carried out on the elutes for
detection of the candidate transcripts in association with the pro-
teins of interest. Interestingly, the exosome associated lncRNAs only
associated with CSF, LDH, and HGM in the context of the recipientPlease cite this article in press as: C. Hewson, et al., Extracellular vesicle
Non-coding RNA Research (2016), http://dx.doi.org/10.1016/j.ncrna.2016.cells (Fig. 4A) and not within the context of the exosome (Fig. 4B).
These observations suggest that the exosome-associated lncRNAs
interact with particular cellular proteins; CSF, LDH and HGM, upon
exosomal entry into the target cells to affect cellular viability.
4. Discussion
To date many studies have been carried out looking at proteins,
mRNAs and even miRNAs associated with exosomes (reviewed in
[31]). However, little work has been carried out with regards to the
association and putative role of lncRNAs in exosome biology. In
light of the emerging realizations that lncRNAs play an underap-
preciated role in controlling chromosomal content, in particular
transcriptional and epigenetic states, we sought to determine those
lncRNAs associated with both Hela and C33A cell exosomes. Weassociated long non-coding RNAs functionally enhance cell viability,
06.001
Fig. 4. Enrichment of various exosome-associated lncRNAs with mass spec identiﬁed proteins e IP was carried out for the various mass spec identiﬁed proteins in triplicate with either
(A) cells or (B) exosomes. The resultant elutes were subjected to qRT-PCR and enrichment of each lncRNA with the candidate protein relative to the IgG negative control following
input standardization. The averages of triplicate IPs are shown.
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(Table S3), with the top 4 most abundant exosome associated
transcripts in both Hela and C33A cells being Exo1-4 (Figs. 1, S1 and
Tables S1 and S2), that mapped to intergenic gene deserts, several
kilobases away from their nearest transcribed coding and/or non-
coding neighbour. These transcripts have been considered ribo-
somal associated transcripts and are found embedded in DNase I
hypersensitive clusters with exceedingly high levels of histone H3
at lysine 27 acetylation (H3K27ac), two chromatinmarks associated
with actively transcribed regions of the genome. Interestingly, we
were unable to observe signiﬁcant enrichment of well-known
lncRNAs involved in human cell cancers, BCYRN1, MALAT1, GAS5
and NEAT1, which have been observed previously to be associated
with exosomes in human cells and human cell cancers
[2,7,8,12,20,28,35,41].
The observations presented here indicate that the top candidate
assessed exosome associated lncRNAs Exo1-4 and RMRP, when
over-expressed in recipient cells, affect cell viability. Mechanisti-
cally, we ﬁnd that the candidate exosome associated lncRNAs
interact directly with several proteins. The exosome associated
lncRNA Exo2 appears to interact directly with lactatePlease cite this article in press as: C. Hewson, et al., Extracellular vesicle
Non-coding RNA Research (2016), http://dx.doi.org/10.1016/j.ncrna.2016.dehydrogenase B (LDHB), while Exo4 and RMRP interact with High
mobility group protein 17 (HMG-17), and Type I cytokine high af-
ﬁnity receptor for IL-3, IL-5 and CSF (CSF2RB) in cells (Fig. 5).
GAPDH is known to bind AU rich transcripts [25] and LDHB is
known to bind RNA speciﬁcally in the NAD þ RNA binding region
[30]. Interestingly, LDHB appears to be packaged into exosomes
[19], though observations here did not indicate that LDHB was
binding directly to any of the exosome associated lncRNAs within
the context of the exosome. Regardless, LDHB may be one protein
that can bind lncRNAs and recruit them speciﬁcally to blebbing
exosomes in particular cell types, though the data presented here
does not suggest this is the case in Hela and C33A cells. Notably, the
proteins LDHB, GAPDH, CSF and HMG-17 found here to be associ-
ated with exosome associated lncRNAs have been reported previ-
ously to be involved in cellular metabolism, nucleosomal
architecture and cell signalling. It is also noteworthy that RMRP
could also have signiﬁcant impacts on cell viability, when intro-
duced to recipient cells from the context of exosomes, by direct cis
interactions in the chromatin, possibly affecting CCDC107 and
ARHGEF39 expression and cell motility (Fig. S3). The exosome-
associated lncRNAs described here don't appear to interact withassociated long non-coding RNAs functionally enhance cell viability,
06.001
Fig. 5. Model for exosomal mediated spread of lncRNAs. (A) RNAs Exo1-4 and RMRP may interact with host proteins or may be free of interactions and be packaged into exosomes
by a speciﬁc, yet to be determined set of exosomal directed proteins. (B) The lncRNA containing exosomes are blebbed from the cell and can then (C) interact with recipient target
cells. Once inside the recipient cells the lncRNAs can (D) bind proteins, such as Exo1, Exo4 and RMRP binding to CSF or Exo2 binding to LDHB or Exo4 binding HGM-17 (HGM) to
affect protein function and cellular states. (E) Some yet to be characterized exosomal-associated lncRNAs such as RMRP may interact with epigenetic regulatory mechanisms to
control particular gene expression states by (F) targeting stable epigenetic marks that may lead to targeted heterochromatin.
C. Hewson et al. / Non-coding RNA Research xxx (2016) 1e98the cellular proteins in the context of the exosome but rather
speciﬁcally inside the recipient cells (Fig. 5), suggesting that the
regulatory effect these exosome associated transcripts play is upon
entry into recipient cells and not within the context of the exosome
per say. Collectively, the observations presented here suggest that
exosome-associated lncRNAs functional modulate cellular protein
function and expand on the ever-growing functional characteristics
of lncRNAs in the human cell. Knowledge of this molecular pathway
may prove useful in controlling cellular micro-environments or in
developing designer RNA packaged exosomes, an eventuality that
could have profound impact on patient speciﬁc disease targeted
therapeutics.
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